预测鼻咽癌放疗后脑坏死对甲泼尼龙反应的影像组学模型
本研究纳入66例接受甲泼尼龙治疗的放射性脑坏死患者,从治疗前脑磁共振图像提取961个影像组学特征,构建并内部验证预测甲泼尼龙反应的影像组学模型。模型结合影像组学标签与放疗至脑坏死诊断的间隔时间,获得AUC 0.966,10折交叉验证乐观校正AUC 0.967,校准曲线一致性良好,决策曲线分析证实临床效用。
要点
- 影像组学标签由16个筛选特征构成,表现出良好的判别性能。
- 影像组学模型结合影像组学标签与放疗至脑坏死诊断的间隔时间,AUC为0.966,10折交叉验证乐观校正AUC为0.967。
- 校准曲线显示良好一致性,决策曲线分析证实模型临床效用。
核心结论
- 所提出的影像组学模型可便捷地用于促进放射性脑坏死患者甲泼尼龙反应的个体化预测。
研究设计与样本
- 纳入66例接受甲泼尼龙治疗的放射性脑坏死患者,从治疗前脑磁共振图像提取961个影像组学特征。
- 采用最小绝对收缩和选择算子回归构建影像组学标签,并结合独立临床预测因子,通过多变量逻辑回归分析构建影像组学模型。
- 对模型的判别、校准和临床有用性进行评估,并使用10折交叉验证进行内部验证。
主要发现
- 影像组学标签由16个筛选特征构成,并获得良好的判别性能。
- 影像组学模型结合影像组学标签与放疗至脑坏死诊断的间隔时间,AUC为0.966,10折交叉验证乐观校正AUC为0.967,显示良好判别性能。
- 校准曲线显示良好一致性,决策曲线分析证实模型的临床效用。
关键数值与推荐
- 影像组学标签由16个筛选特征构成。
- 影像组学模型结合影像组学标签与放疗至脑坏死诊断的间隔时间,AUC为0.966,10折交叉验证乐观校正AUC为0.967。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Methylprednisolone is recommended as the front-line therapy for radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma. However, some patients fail to benefit from methylprednisolone or even progress. This study aimed to develop and validate a radiomic model to predict the response to methylprednisolone in RN. METHODS: Sixty-six patients receiving methylprednisolone were enrolled. In total, 961 radiomic features were extracted from the pre-treatment magnetic resonance imagings of the brain. Least absolute shrinkage and selection operator regression was then applied to construct the radiomics signature. Combined with independent clinical predictors, a radiomics model was built with multivariate logistic regression analysis. Discrimination, calibration and clinical usefulness of the model were assessed. The model was internally validated using 10-fold cross-validation. RESULTS: The radiomics signature consisted of 16 selected features and achieved favorable discrimination performance. The radiomics model incorporating the radiomics signature and the duration between radiotherapy and RN diagnosis, yielded an AUC of 0.966 and an optimism-corrected AUC of 0.967 via 10-fold cross-validation, which also revealed good discrimination. Calibration curves showed good agreement. Decision curve analysis confirmed the clinical utility of the model. CONCLUSIONS: The presented radiomics model can be conveniently used to facilitate individualized prediction of the response to methylprednisolone in patients with RN.
引用
- Zhuo X, Zhao H, Chen M, et al. A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma. Radiat Oncol. 2023. PMID: 36859353. doi:10.1186/s13014-023-02235-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。